Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Telix Pharmaceuticals Ltd banner

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 13.41 AUD 2.92% Market Closed
Market Cap: AU$4.5B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall St Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 24.44 AUD with a low forecast of 18.18 AUD and a high forecast of 33.6 AUD.

TLX Lowest Forecast
18.18 AUD
36% Upside
TLX Average Forecast
24.44 AUD
82% Upside
TLX Highest Forecast
33.6 AUD
151% Upside
Lowest Forecast
Price Target
18.18 AUD
36% Upside
Average Forecast
Price Target
24.44 AUD
82% Upside
Highest Forecast
Price Target
33.6 AUD
151% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
LVS
Las Vegas Sands Corp
35% Upside
PTCT
PTC Therapeutics Inc
24% Upside
AYTU
Aytu Biopharma Inc
323% Upside
NCSM
NCS Multistage Holdings Inc
66% Upside
LVS
Las Vegas Sands Corp
35% Upside
PTCT
PTC Therapeutics Inc
24% Upside
AYTU
Aytu Biopharma Inc
323% Upside
NCSM
NCS Multistage Holdings Inc
66% Upside
PTEN
Patterson-UTI Energy Inc
6% Upside
8961
Mori Trust Sogo Reit Inc
6% Upside
QXO
SilverSun Technologies Inc
95% Upside

Revenue
Forecast

228% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
228% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat
N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
38%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 41%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
26%
Average Beat

What are analyst estimates?

See Also

Summary
TLX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLX stock valuation using valuation multiples.
Wall St Estimates
TLX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Telix Pharmaceuticals Ltd listings:
OTC • USD
TLPPF
 F • EUR
T3X
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TLX's stock price target?
Price Target
24.44 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 24.44 AUD with a low forecast of 18.18 AUD and a high forecast of 33.6 AUD.

What is the Revenue forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Revenue has been 228%. The projected CAGR for the next 8 years is 12%.

What is the Operating Income forecast for Telix Pharmaceuticals Ltd?
Projected CAGR
41%

The compound annual growth rate for Operating Income over the next 8 years is 41%.

Back to Top
ALPHA SPREAD
Follow us
Join 340,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett